Mielóma multiplex: vizsgálatok itt: Egyesült Államok
297 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleUse of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
- Where
- Chicago, Salt Lake City
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Utah
See details and how to joinNCT06517017 - No phaseTaking peopleNeurocognitive Trajectories After BCMA CAR-T
- Where
- Charlotte
- Életkor
- 18 év and over
- People
- 50
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07740317 - 1. fázisTaking peopleA Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Where
- Ann Arbor, Atlanta, Boston, Charleston, Charlotte, Cleveland, Dallas, Durham, Hackensack, Houston, Jacksonville, Miami, Nashville, New York, Philadelphia, Rochester, San Francisco, Tacoma
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- K36 Therapeutics, Inc.
See details and how to joinNCT05651932 · EU 2022-500801-41-00 - 2. fázisTaking peopleGeriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
- Where
- Columbus, Duarte, Irvine, Winston-Salem
- Életkor
- 60 év and over
- People
- 164
- Run by
- City of Hope Medical Center
See details and how to joinNCT06052826 - 1. fázisNot yet taking people in Egyesült ÁllamokMicrobiome Intervention for CAR-T Optimization and Response (MICRO-CART)
- Where
- Chicago
- Életkor
- 18 év and over
- People
- 32
- Run by
- University of Chicago
See details and how to joinNCT07871747 - 3. fázisNot yet taking people in Egyesült ÁllamokA Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
- Where
- Atlanta, Austin, Boston, Chapel Hill, Charlotte, Charlottesville, Chicago, Cleveland, Columbus, Dallas, Denver, Detroit, Durham, Gilbert, Goodyear, Great Neck, Houston, Jacksonville, Lexington, Los Angeles, Madison, Milwaukee, Newnan, New York, Orange, Philadelphia, Phoenix, Portland, Rochester, San Antonio, San Francisco, Seattle, Stanford, St Louis, Stony Brook, Tampa, The Bronx, Winston-Salem, Zion
- Életkor
- 18 év to 130 év
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07735637 - 1. fázisTaking peopleA Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Atlanta, Denver, Detroit, Duarte, Irvine, St Louis
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT04910568 · EU 2023-507019-36-00 - 2. fázisTaking peoplePost-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
- Where
- Houston
- Életkor
- 18 év to 72 év
- People
- 61
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05776979 - 3. fázisTaking peopleWisconsin Ginseng for Decreasing Cancer Related Fatigue
- Where
- Albert Lea, Bemidji, Brainerd, Deer River, Detroit Lakes, Duluth, Fosston, Hibbing, Mankato, Monticello, Rochester, Sandstone, Thief River Falls, Virginia, Worthington
- Életkor
- 18 év and over
- People
- 222
- Run by
- Mayo Clinic
See details and how to joinNCT06395441 - 1. fázisTaking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Életkor
- 18 év and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017 - 1. fázisTaking peopleA Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- Where
- Chicago, Denver, Duarte, Grand Rapids, Irvine, Newnan, Tampa
- Életkor
- 18 év and over
- People
- 127 worldwide
- Run by
- AbbVie
See details and how to joinNCT07409246 - 1/2. fázisTaking peopleA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Where
- Atlanta, Chapel Hill, Charlotte, Cincinnati, Columbus, Dallas, Denver, Duarte, Irvine, New York, Salt Lake City, San Francisco, Tampa, Winston-Salem
- Életkor
- 18 év to 64 év
- People
- 602 worldwide
- Run by
- AbbVie
See details and how to joinNCT06892522 · EU 2024-515770-27-00 - 2/3. fázisTaking peopleA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Where
- Atlanta, Chapel Hill, Denver, Eugene, Fairfax, Fort Wayne, Los Angeles, Minneapolis, Nashville, New York, Roanoke, Rochester, Scottsdale, The Woodlands, Tyler
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- AbbVie
See details and how to joinNCT07095452 · EU 2025-520897-21-00 - No phaseTaking peopleLeukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Where
- Chicago, Miami, San Antonio
- Életkor
- 18 év and over
- People
- 400
- Run by
- University of Miami
See details and how to joinNCT05745285 - 1/2. fázisTaking peopleTesting the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 162
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07463807 - 2. fázisCsak meghívásosInternational Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Sanofi
See details and how to joinNCT05669989 - 1. fázisTaking peopleRecombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 52
- Run by
- Washington University School of Medicine
See details and how to joinNCT07200089 - 1. fázisTaking peopleSelinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 20
- Run by
- Washington University School of Medicine
See details and how to joinNCT07200102 - 1/2. fázisTaking peopleA Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Atlanta, Cleveland, Denver, Duarte, Hackensack, Houston, Milwaukee, Nashville, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 101 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07681596 - 2. fázisTaking peopleCAR T-cell Therapy in Patients With Renal Dysfunction
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 20
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT05909059 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Baltimore, Bethesda, Cincinnati, Coral Springs, Denver, Durham, Hackensack, Hershey, Houston, Jacksonville, Lafayette, Milwaukee, Morristown, New York, Orange, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 1. fázisTaking peopleA Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 18
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07105059 - No phaseTaking peopleA Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07249528 - 3. fázisTaking peopleD2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM
- Where
- Boston
- Életkor
- 18 év to 75 év
- People
- 720
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07624513 - 1/2. fázisTaking peopleAZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Where
- Ann Arbor, Atlanta, Aurora, Austin, Birmingham, Boston, Buffalo, Charlotte, Charlottesville, Chicago, Dallas, Denver, Detroit, Durham, Edmonds, Hackensack, Houston, Iowa City, Jacksonville, La Jolla, Los Angeles, Miami, Milwaukee, Minneapolis, Nashville, New York, Omaha, Phoenix, Rochester, Salt Lake City, San Francisco, Seattle, Stony Brook, Tampa
- Életkor
- 18 év and over
- People
- 232
- Run by
- AstraZeneca
See details and how to joinNCT05850234